Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform with the Addition of MOSS EOS for Early Onset Scoliosis Surgery

Contributed by: Business Wire

Images

Business Wire associated0
Business Wire associated1
Business Wire embedded0

Tags

Professional Services
Health
Medical Devices
Thought Leadership
Surgery
Health Technology
Biotechnology
MOSS!MODULARITY Platform

More Like This

MOSS!MODULARITY Injection Screw

Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform and Announces Introduction of Multiple New Products

Business Wire associated0

Biedermann Medtech Group Announces Transformation of U.S. Spine Market Approach and New Business Model

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage

The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement

Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage